Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

VA Launches a Randomized Trial Testing Whether Semaglutide Can Reduce Drinking in Veterans

The VA opened enrollment in CRAVE, a placebo-controlled trial of semaglutide for alcohol use disorder in more than 600 veterans at 18 medical centers.

Medical Daily

VA Begins Enrolling 600 Veterans in Trial Testing Whether Semaglutide Reduces Alcohol Use

The VA launched a placebo-controlled trial of semaglutide for alcohol use disorder in 600 veterans. No results exist yet. Here is what it tests.

Medical Daily

How people in Chile's Atacama Desert evolved to survive drinking arsenic-poisoned water

For most of human history, a water source containing high concentrations of arsenic would have been considered deadly. Long-term exposure to the toxic metal is linked to cancers, cardiovascular disease, diabetes and neurological disorders. Yet for thousands of years, people living in Chile's Atacama Desert have relied on groundwater containing…

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

Government tightens surveillance on GLP-1 weight-loss drug promotion amidst surrogate advertising concerns

Central government directs state regulators to enhance surveillance over GLP-1 drug promotion. Approved GLP-1 drugs are only for Type 2 diabetes and specific weight management. Advisories were issued to manufacturers and drug controllers regarding product information. Regulators must monitor supply chains and take action against diversion. Advertising platforms will be…

The Economic Times

Type 2 diabetes patients on metformin, take note: After 60 years, scientists find this drug has hidden effects on the brain

Diabetes: Recent studies reveal that metformin may influence blood sugar management via the brain. This medication stimulates a distinct brain pathway responsible for glucose regulation. Remarkably, researchers observed that a small dose significantly reduced blood sugar levels in mice. This groundbreaking finding has the potential to pave the way for…

The Economic Times

'Floaters' do not pose a risk to your eye health

Dear Doctors: I was recently diagnosed with "floaters" in my right eye. I am told it just happens and is not my diabetes or high blood pressure. The floaters are constant and only get better with sunglasses. They make eye-involved activities difficult, and I get somewhat carsick. Any suggestions?

Bangkok Post

FDA Names Its First Company in a Pilot That Lets Some Digital Health Devices Skip Premarket Review

The FDA selected Dexcom as the first participant in its TEMPO pilot, which pairs relaxed premarket review with real-world evidence collection.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Type 2 diabetes medicine widely used since 1922 may affect blood sugar patient's brain, claims recent study

Metformin may have been part of diabetes medicine for generations, but scientists are still uncovering new chapters in its story. The possibility that the brain participates in its glucose-lowering action is a reminder that the human body's metabolic system is deeply interconnected—and that even some of medicine's oldest tools can…

The Economic Times

5 Silent Causes of Liver Cirrhosis in Non-Drinkers in India: Fatty Liver, Hepatitis and More

Nonalcoholic Fatty Liver Disease: The Epidemic Nobody Sees ComingNonalcoholic fatty liver disease, NAFLD, is now the most common chronic liver condition in India, affecting an estimated 9 to 32 percent of the general population, according to data published in the Journal of Clinical and Experimental Hepatology. The numbers are worse…

Times Life

From Cancer to Diabetes: Studies reveal these food preservatives may be linked to serious health problems

Two large French studies suggest some common food preservatives may be linked to a higher risk of cancer and type 2 diabetes. However, researchers say the findings show an association, not a direct cause-and-effect relationship. They recommend choosing less processed foods while further research explores these links.

The Economic Times

6 Simple Changes That May Protect Your Brain From Stroke

Stroke often seems like a sudden medical emergency that happens without warning. However, doctors say that many strokes are linked to health conditions and daily habits that develop quietly over time. The good news is that small lifestyle changes made today may significantly reduce your future risk. From checking your…

MyLifeXP

Three Medical Device Categories Established in 2023 Are Now Officially Codified by the FDA

FDA codified three device categories covering a kidney risk test, a diabetes therapy app, and at-home COVID tests. All were classified in 2023.

Medical Daily

The Claim That Weight Loss Does Not Prevent Diabetes Is Circulating Again, and the Study Behind It Is Narrower Than That

A recent study says weight loss may not prevent type 2 diabetes. Here is what it actually found and who it applies to.

Medical Daily

Vibrio vulnificus symptoms to know as Florida sees another ‘flesh-eating bacteria’ case

Another person has contracted flesh-eating bacteria in Florida , bringing the state’s total to 12 cases and one death so far this year. The latest patient is someone in their late 30s in Bay County, according to the Florida health department. The state saw a death in June, when a…

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

MyLifeXP

Makhana or Roasted Chana: Which Is Better for Weight Loss

Increased knowledge about the harm that can be done by junk foods, Indians have resorted to more traditional healthful snacking. Two such healthy snacks include makhana) and roasted chana both tasty and nutritious. The health that continues to be popular among rural and semi-urban Indians due to its lower price…

Medical Daily

GLP-1 Drugs Did Not Lower Relapse Risk in Crohn's and Colitis Patients, a Large Claims Analysis Found

A claims study found GLP-1 drugs did not reduce IBD relapse in patients with obesity or diabetes, and did not raise safety events.

Medical Daily

One Prediabetes Subgroup Kept Sliding Toward Diabetes Despite Years of Sustained Weight Loss

One prediabetes subgroup kept progressing toward diabetes despite sustained 8% weight loss and the steepest drop in insulin secretion.

The Guardian - UK

Black people’s risk factors for stroke ‘rising faster than for white people’

Exclusive: King’s College London analysis finds diabetes and hypertension are more common in Black African and Caribbean people

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Millions Take Metformin Daily: Here Is What New Research Says About How It Actually Works

New research suggests metformin works mainly in the gut, not the liver. Here is the plain-language explanation and why nothing about your dosing changes.

Medical Daily

Daily Oral Weight Loss Pill Outperformed Oral Semaglutide On Weight And Blood Sugar In Type 2 Diabetes

In a 1,698-person trial, orforglipron beat oral semaglutide on A1C and weight in type 2 diabetes. Here is what was measured and what was not.

Medical Daily

ICER Finds Weight-Loss Drugs Cost-Effective, But Analysts Warn the Projected Savings Depend on Patients Staying On Them

ICER finds GLP-1s cost-effective for obesity, but analysts warn projected savings assume patients stay on treatment. What it means for coverage.

We Got This Covered

A woman new to United Healthcare is surprised when a prescription to battle pre-diabetes is denied. Then they allegedly sent her a bathroom scale

They did note that the scale was “really nice.”

Medical Daily

Patients Paid Less for GLP-1s While Total Spending Climbed, and Formularies Have Been Swinging Ever Since

A study found GLP-1 out-of-pocket costs fell as total spending rose. Here is what formulary swings mean for your coverage at renewal.

International Business Times UK

Ozempic Side Effects: What New Research Reveals About the Risks and What Happens When You Stop

Ozempic aids in weight loss and diabetes management but raises concerns about side effects and weight regain post-treatment, highlighting the need for informed decision-making and long-term management strategies.

Medical Daily

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk

A new BMJ study links Ozempic and Mounjaro to 37–68% higher hair loss risk. The FDA is evaluating a safety signal. What patients need to know before their next dose.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Nature Communications

the US Food and Drug Administration

74 stories

United Healthcare

72 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.